Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Botox’s First Major Rival Cleared for Sale in U.S.

Posted Apr 30 2009 12:00am

Ipsen SA and Medicis Pharmaceutical Corp. won U.S. Food and Drug Administration approval to sell their product, Dysport, for both aesthetic and therapeutic uses, the companies said today in a statement. Like Allergan Inc.’s Botox, the new injection uses a type of botulinum toxin to relax the muscles that cause forehead lines and a neck-twisting disorder called cervical dystonia.

Unless Allergan pays to not have this hit the market , this drug will severely cut into Allergan’s bottom line in the next few years.

Best Regards,

John Di Saia MD

Post a comment
Write a comment: